PTEN gene mutation and high MIB-1 labeling index may contribute to dissemination in patients with glioblastoma
暂无分享,去创建一个
[1] T. Yoshimine,et al. PTEN Mutations in Malignant Gliomas and their Relation with Meningeal Gliomatosis , 2001, Journal of Neuro-Oncology.
[2] Y. Okada,et al. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma. , 2001, Journal of neurosurgery.
[3] T. Yoshimoto,et al. Functional evaluation of p53 and PTEN gene mutations in gliomas. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[4] C. James,et al. Analysis of oncogene and tumor suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with PTEN mutations. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[5] Erwin G. Van Meir,et al. The PTEN lipid phosphatase domain is not required to inhibit invasion of glioma cells. , 1999, Cancer research.
[6] G. Schackert,et al. Genetic alterations of the tumor suppressor gene PTEN/MMAC1 in human brain metastases. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[7] Kenneth M. Yamada,et al. PTEN Interactions with Focal Adhesion Kinase and Suppression of the Extracellular Matrix-dependent Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway* , 1999, The Journal of Biological Chemistry.
[8] Kenneth M. Yamada,et al. Tumor Suppressor PTEN Inhibits Integrin- and Growth Factor–mediated Mitogen-activated Protein (MAP) Kinase Signaling Pathways , 1998, The Journal of cell biology.
[9] W. Yung,et al. Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: relationship to prognostic significance. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[10] Kenneth M. Yamada,et al. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. , 1998, Science.
[11] D. Louis,et al. PTEN mutations in gliomas and glioneuronal tumors , 1998, Oncogene.
[12] W. Isaacs,et al. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. , 1998, Cancer research.
[13] J. Bruce,et al. Somatic mutations of PTEN in glioblastoma multiforme. , 1997, Cancer research.
[14] R. McLendon,et al. PTEN gene mutations are seen in high-grade but not in low-grade gliomas. , 1997, Cancer research.
[15] P. Guldberg,et al. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. , 1997, Cancer research.
[16] W. K. Alfred Yung,et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers , 1997, Nature Genetics.
[17] M. Wigler,et al. PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.
[18] M. Emi,et al. Allelic losses at loci on chromosome 10 are associated with metastasis and progression of human prostate cancer , 1996, Genes, chromosomes & cancer.
[19] H. Woo,et al. Disseminated ependymomas of the central nervous system. , 1996, Journal of neurosurgery.
[20] J. Thalabard,et al. Progestogen use and decreased risk of breast cancer in a cohort study of premenopausal women with benign breast disease. , 1994, British Journal of Cancer.
[21] M. Berger,et al. Ventricular entry during resection of malignant gliomas: effect on intracranial cerebrospinal fluid tumor dissemination. , 1994, Journal of neurosurgery.
[22] M. Key,et al. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[23] R. Selker,et al. Brain stem and spinal metastases of supratentorial glioblastoma multiforme: a clinical series. , 1990, Neurosurgery.
[24] I. Awad,et al. Leptomeningeal metastasis from supratentorial malignant gliomas. , 1986, Neurosurgery.
[25] R. Packer,et al. Leptomeningeal dissemination of primary central nervous system tumors of childhood , 1985, Annals of neurology.
[26] R. Weller,et al. International Histological Classification of Tumours , 1981 .
[27] W. Shapiro,et al. Meningeal gliomatosis: A review of 12 cases , 1980, Annals of neurology.
[28] R. Davis,et al. Spinal subarachnoid metastasis from primary intracranial glioblastoma multiforme , 1978, Cancer.
[29] P. Rubin,et al. The spread of glioblastoma multiforme as a determining factor in the radiation treated volume. , 1976, International journal of radiation oncology, biology, physics.
[30] T. Kawase,et al. Correlation between MIB-1 staining indices and recurrence in low-grade astrocytomas , 2006, Brain Tumor Pathology.
[31] M. Taneda,et al. Leptomeningeal dissemination of malignant gliomas. Incidence, diagnosis and outcome , 2005, Acta Neurochirurgica.
[32] H. Singer,et al. Cerebrospinal metastases in malignant childhood astrocytomas , 2004, Journal of Neuro-Oncology.
[33] W. Yung,et al. Advances in Brief Differential Expression of MMAC / PTEN in Glioblastoma Multiforme : Relationship to Localization and Prognosis 1 , 1999 .
[34] S. Petersen,et al. Allelic loss on chromosome 10q in human lung cancer: association with tumour progression and metastatic phenotype. , 1998, British Journal of Cancer.
[35] A. L. Albright,et al. Dissemination of supratentorial malignant gliomas via the cerebrospinal fluid in children. , 1992, Neurosurgery.